[go: up one dir, main page]

AU2238192A - Modified peptides transportable into the central nervous system - Google Patents

Modified peptides transportable into the central nervous system

Info

Publication number
AU2238192A
AU2238192A AU22381/92A AU2238192A AU2238192A AU 2238192 A AU2238192 A AU 2238192A AU 22381/92 A AU22381/92 A AU 22381/92A AU 2238192 A AU2238192 A AU 2238192A AU 2238192 A AU2238192 A AU 2238192A
Authority
AU
Australia
Prior art keywords
transportable
nervous system
central nervous
modified peptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22381/92A
Inventor
Argyrios Arvantis
Gary Avonn Cain
Thomas Eugene Christos
Pasquale Nicholas Confalone
Richard Scott Pottorf
William Koch Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Publication of AU2238192A publication Critical patent/AU2238192A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/083—Neurotensin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU22381/92A 1991-06-27 1992-06-18 Modified peptides transportable into the central nervous system Abandoned AU2238192A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72361691A 1991-06-27 1991-06-27
US723616 1991-06-27

Publications (1)

Publication Number Publication Date
AU2238192A true AU2238192A (en) 1993-01-25

Family

ID=24906998

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22381/92A Abandoned AU2238192A (en) 1991-06-27 1992-06-18 Modified peptides transportable into the central nervous system

Country Status (2)

Country Link
AU (1) AU2238192A (en)
WO (1) WO1993000359A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU674525B2 (en) * 1992-06-01 1997-01-02 Magainin Pharmaceuticals, Inc. Biologically active peptides having N-terminal substitutions

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022906A1 (en) * 1993-03-26 1994-10-13 Warner-Lambert Company Inhibitors of endothelin converting enzyme
AU6913994A (en) * 1993-05-13 1994-12-12 New York University Psychosis protecting nucleic acid, peptides, compositions and method of use
DE19943635A1 (en) 1999-09-13 2001-03-15 Bayer Ag Novel aminodicarboxylic acid derivatives with pharmaceutical properties
DE10109861A1 (en) 2001-03-01 2002-09-05 Bayer Ag Novel side chain halogenated aminodicarboxylic acid derivatives
DE10109858A1 (en) 2001-03-01 2002-09-05 Bayer Ag Novel halogen-substituted aminodicarboxylic acid derivatives
JP2008534542A (en) * 2005-03-31 2008-08-28 ユセベ ファルマ ソシエテ アノニム Compounds containing an oxazole moiety or a thiazole moiety, processes for their preparation and their use
TW201136942A (en) 2009-12-18 2011-11-01 Idenix Pharmaceuticals Inc 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
WO2015092792A1 (en) * 2013-12-20 2015-06-25 Yissum Research Develoment Company Of The Hebrew University Of Jerusalem Ltd. Pro-angiogenic peptides and peptide conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425269A (en) * 1982-06-07 1984-01-10 Merck & Co., Inc. Metabolically protected analogs of neurotensin
FI890918A7 (en) * 1988-03-11 1989-09-12 Eisai Co Ltd POLYPEPTIDES.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU674525B2 (en) * 1992-06-01 1997-01-02 Magainin Pharmaceuticals, Inc. Biologically active peptides having N-terminal substitutions

Also Published As

Publication number Publication date
WO1993000359A1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
HK1004896B (en) Peptides
GB2269176B (en) Peptides
ZA928511B (en) Peptides
AU3925193A (en) Inflatable wrist-stabilizing system
AU6018194A (en) Easy intubator
AU4767193A (en) Transportable dwelling unit
AU7055394A (en) Transportable easel
DE69326254D1 (en) Membrane
AU7465794A (en) Probiotics
DE68908893D1 (en) Faltbare transportable brücke.
GB9405231D0 (en) Simple compositioning system
AU2993492A (en) Improved neck
AU2238192A (en) Modified peptides transportable into the central nervous system
ZA942543B (en) Tetrohydro beta-carbolines
GB9226065D0 (en) Peptides
ZA947754B (en) Pharmaceutical combinations
EP0579611A4 (en) Peptides.
AU3734693A (en) Neurotrophic peptides
ZA931299B (en) Novel peptides
AU4763293A (en) Transporter
AU1198192A (en) Novel peptide
AU1707892A (en) Gastrin-binding protein
AU1020092A (en) Support means
AU1631692A (en) Securing means
AU1270992A (en) Canter